These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20447801)

  • 1. Breakthrough pain in oncology: a longitudinal study.
    Mercadante S; Zagonel V; Breda E; Arcara C; Gebbia V; Porzio G; Aielli F; David F; Gammucci T; Narducci F; Lanzetta G; Restuccia R; Lembo A; Passeri V; Virzì V; Casuccio A
    J Pain Symptom Manage; 2010 Aug; 40(2):183-90. PubMed ID: 20447801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of patient coaching on analgesic treatment adjustment: secondary analysis of a randomized controlled trial.
    Kravitz RL; Tancredi DJ; Jerant A; Saito N; Street RL; Grennan T; Franks P
    J Pain Symptom Manage; 2012 May; 43(5):874-84. PubMed ID: 22560357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the Cancer Pain Outcome Research Study Group.
    Greco MT; Corli O; Montanari M; Deandrea S; Zagonel V; Apolone G; ;
    Clin J Pain; 2011 Jan; 27(1):9-18. PubMed ID: 20842024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of analgesic prescription and patient adherence on pain in a dutch outpatient cancer population.
    Enting RH; Oldenmenger WH; Van Gool AR; van der Rijt CC; Sillevis Smitt PA
    J Pain Symptom Manage; 2007 Nov; 34(5):523-31. PubMed ID: 17664055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study.
    Fisher K; Stiles C; Hagen NA
    J Pain Symptom Manage; 2004 Dec; 28(6):619-25. PubMed ID: 15589088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence rates for and predictors of self-reported adherence of oncology outpatients with analgesic medications.
    Valeberg BT; Miaskowski C; Hanestad BR; Bjordal K; Moum T; Rustøen T
    Clin J Pain; 2008 Sep; 24(7):627-36. PubMed ID: 18716502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported prevalence, etiology, and characteristics of pain in oncology outpatients.
    Valeberg BT; Rustøen T; Bjordal K; Hanestad BR; Paul S; Miaskowski C
    Eur J Pain; 2008 Jul; 12(5):582-90. PubMed ID: 18023377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing patients' satisfaction and intensity of pain as outcomes in the management of cancer-related pain.
    Panteli V; Patistea E
    Eur J Oncol Nurs; 2007 Dec; 11(5):424-33. PubMed ID: 18053765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough pain in advanced cancer patients followed at home: a longitudinal study.
    Mercadante S; Costanzo BV; Fusco F; Buttà V; Vitrano V; Casuccio A
    J Pain Symptom Manage; 2009 Oct; 38(4):554-60. PubMed ID: 19692200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do we need to improve pain management in the radiation oncology department?
    Janjan N
    Nat Clin Pract Oncol; 2005 Mar; 2(3):130-1. PubMed ID: 16264903
    [No Abstract]   [Full Text] [Related]  

  • 11. No evidence for sex differences in the severity and treatment of cancer pain.
    Edrington JM; Paul S; Dodd M; West C; Facione N; Tripathy D; Koo P; Schumacher K; Miaskowski C
    J Pain Symptom Manage; 2004 Sep; 28(3):225-32. PubMed ID: 15336334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differences in the prescription of analgesics in the treatment of cancer pain in six Danish pain treatment units].
    Olesen AE; Jarvig L; Hansen OB; Højsted J; Jensen NH; Jonsson T; Sjøgren P; Sonne NM; Sørensen JT; Christrup LL
    Ugeskr Laeger; 2007 May; 169(21):2024-9. PubMed ID: 17553385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pain treatment practice according to the WHO analgesic ladder in cancer patients: eight years experience of a single center].
    Orhan ME; Bilgin F; Ergin A; Dere K; Güzeldemir ME
    Agri; 2008 Oct; 20(4):37-43. PubMed ID: 19117155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough pain in children with cancer.
    Friedrichsdorf SJ; Finney D; Bergin M; Stevens M; Collins JJ
    J Pain Symptom Manage; 2007 Aug; 34(2):209-16. PubMed ID: 17553659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
    Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
    Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric cancer pain management using the WHO analgesic ladder--results of a prospective analysis from 2265 treatment days during a quality improvement study.
    Zernikow B; Smale H; Michel E; Hasan C; Jorch N; Andler W
    Eur J Pain; 2006 Oct; 10(7):587-95. PubMed ID: 16243549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Prevalence of pain in hospitalized patients].
    Cañellas M; Bosch F; Bassols A; Rué M; Baños JE
    Med Clin (Barc); 1993 Jun; 101(2):51-4. PubMed ID: 8510476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen.
    Mercadante S; Villari P; Ferrera P; Mangione S; Casuccio A
    Clin J Pain; 2010 May; 26(4):306-9. PubMed ID: 20393265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI--Italian questionnaire for intense episodic pain.
    Caraceni A; Bertetto O; Labianca R; Maltoni M; Mercadante S; Varrassi G; Zaninetta G; Zucco F; Bagnasco M; Lanata L; De Conno F;
    J Pain Symptom Manage; 2012 May; 43(5):833-41. PubMed ID: 22560355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study.
    Lennernäs B; Frank-Lissbrant I; Lennernäs H; Kälkner KM; Derrick R; Howell J
    Palliat Med; 2010 Apr; 24(3):286-93. PubMed ID: 20015921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.